Age-linked suppression of lipoxin A4 mediates cognitive deficits in mice and humans
Pamplona, F. A.; Vitoria, G.; Ribeiro, F. C.; Moraes, C. A.; Ledur, P. F.; Karmirian, K.; Ornelas, I. M.; Leo, L. M.; Paulsen, B.; Sudo, F. K.; Coutinho, G.; Drummond, C.; Assuncao, N.; Vanderborght, B.; Canetti, C.; Castro-Faria-Neto, H. C.; Mattos, P.; Ferreira, S. T.; Rehen, S. K.; Bozza, F. A.; Lourenco, M. V.; Tovar-Moll, F.
Show abstract
Age increases the risk for cognitive impairment and is the single major risk factor for Alzheimers disease (AD), the most prevalent form of dementia in the elderly. The pathophysiological processes triggered by aging that render the brain vulnerable to dementia involve, at least in part, changes in inflammatory mediators. Here we show that lipoxin A4 (LXA4), a lipid mediator of inflammation resolution known to stimulate endocannabinoid signaling in the brain, is reduced in the aging central nervous system. We demonstrate that genetic suppression of 5-lipoxygenase (5-LOX), the enzyme mediating LXA4 synthesis, promotes learning impairment in mice. Conversely, administration of exogenous LXA4 attenuated cytokine production and memory loss induced by inflammation in mice. We further show that cerebrospinal fluid LXA4 is reduced in patients with dementia and positively associates with memory performance, brain-derived neurotrophic factor (BDNF), and AD-linked amyloid-. Our findings suggest that reduced LXA4 levels may lead to vulnerability to age-related cognitive disorders and that promoting LXA4 signaling may comprise an effective strategy to prevent early cognitive decline in AD.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Long-lived adult-born hippocampal neurons promote successful cognitive aging 96%
- Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer's disease-like pathology in human cerebral organoids 96%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 96%
Similar papers in this journal
- AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer's disease 97%
- Knockout of TSPO delays and reduces amyloid, Tau, astrocytosis and behavioral dysfunctions in Alzheimer's disease. 96%
- Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models 95%
Similar papers in this journal
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 95%
- Diabetic phenotype in mouse and humans with β-amyloid pathology reduces the number of microglia around β-amyloid plaques 95%
- A Microglial Activity State Biomarker Panel Differentiates Ftd-Granulin And Ad From Control Cases 95%
Similar papers in this journal
- Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy 97%
- Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer's disease 96%
- Transcriptomic and functional analysis of Aβ1-42 oligomer-stimulated human monocyte-derived microglia-like cells 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.